gvtcx

Provision of Sequencing Equipment and Consumables

Guy's and St Thomas' NHS Foundation Trust Published 22 Apr 2024 Contracts Finder

key details

Value£376,110
Statuscomplete
Category (CPV) 33140000 +1 more
Deadline27 Mar 2024
Contract start31 Mar 2024
Contract end31 Mar 2026
Procedurelimited
SME suitableNo
OCIDocds-b5fd17-7d268df2-fdc1-4c75-b86a-4596ebac20f6

Awards (2)

This procurement was awarded to 1 suppliers. Values shown are per-award; the notice total is £376,110.

SupplierValueDateStatus
OXFORD NANOPORE TECHNOLOGIES PLC £376,110 27 Mar 2024 active
OXFORD NANOPORE TECHNOLOGIES PLC · · active

description

Guys and St Thomas's NHS Foundation Trust (GSTT) has been awarded Funding from NHS England (NHSE) and the Department of Science, Innovation and Technology (the "Funders") for the financial years 2023/24 and 2024/25 as the lead provider for the delivery of the Respiratory Metagenomic Clinical Service Development Programme (the 'Project'), from Oxford Nanopore Technologies PLC.

The Project is a pilot based on patented nanopore based sequencing technology and therefore this contract notice is issued under Regulation 32 (a) of the PCR 2015.

The Project aims to deliver a national respiratory metagenomics (RMg) pilot clinical service with an integrated biosecurity surveillance purpose, as a world-first programme to combine effective infectious disease management with rapid emerging pathogen detection and notification.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
22 Apr 2024 Contract award notice (F03) Earlier regulations 012957-2024
22 Apr 2024 Award (award) · dd0f1a4d-85d9-4f61-ac7e-fc3ef72a1a24-742968

more from Guy's and St Thomas' NHS Foundation Trust

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.